Once-daily insulin detemir in a cohort of insulin-naïve patients with type 2 diabetes: a sub-analysis from the PREDICTIVE study

By Meneghini L. F.   Dornhorst A.   Sreenan S.  

Current Medical Research and Opinion, Vol. 25, Iss. 4, 2009-04 ,pp. : 1029-1035

Informa Healthcare

Access to resources Recommend Favorite

Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study

By Wenying Yang   Benroubi Marian   Borzi Vito   Gumprecht Janusz   Kawamori Ryuzo   Shaban Joseph   Shah Siddharth   Shestakova Marina   Ligthelm Robert   Valensi Paul  

Current Medical Research and Opinion, Vol. 25, Iss. 11, 2009-11 ,pp. : 2643-2654

Informa Healthcare

Access to resources Recommend Favorite

Weight‐neutral effect of insulin detemir

By  

JOURNAL OF DIABETES, Vol. 7, Iss. 2, 2015-03 ,pp. : 222-230

John Wiley & Sons Inc

Access to resources Recommend Favorite

Higher insulin detemir doses are required for the similar glycemic control: comparison of insulin detemir and glargine in children with type 1 diabetes mellitus

By  

PEDIATRIC DIABETES (ELECTRONIC), Vol. 16, Iss. 5, 2015-08 ,pp. : 361-366

John Wiley & Sons Inc

Access to resources Recommend Favorite

The glycemic efficacies of insulin analogue regimens according to baseline glycemic status in Korean patients with type 2 diabetes: sub‐analysis from the A1chieve® study

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 68, Iss. 11, 2014-11 ,pp. : 1338-1344

John Wiley & Sons Inc

Access to resources Recommend Favorite